{"recordsFiltered":48720,"recordsTotal":48720,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&start=38100","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&start=37500","results":[{"registry_id":"NCT07020923","publication_url":"https://clinicaltrials.gov/study/NCT07020923","title":"A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients With IgAN","has_exemption":false,"start_date":"2025-05-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vera Therapeutics, Inc.","sponsor_slug":"vera-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06799052","publication_url":"https://clinicaltrials.gov/study/NCT06799052","title":"Same-Day Cervical Preparation Prior to Second Trimester Dilation & Evacuation: A Noninferiority Randomized Control Trial Comparing Single-Balloon Catheter and Osmotic Dilators","has_exemption":false,"start_date":"2025-06-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07244939","publication_url":"https://clinicaltrials.gov/study/NCT07244939","title":"Cephea South America Feasibility Study","has_exemption":false,"start_date":"2025-06-17","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06912633","publication_url":"https://clinicaltrials.gov/study/NCT06912633","title":"A Randomized, Masked, Sham-Controlled Phase 2 Trial of the Safety of a Single Intravitreal Injection of jCell (Famzeretcel) for the Treatment of Retinitis Pigmentosa (RP)","has_exemption":false,"start_date":"2025-06-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"jCyte, Inc","sponsor_slug":"jcyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07019259","publication_url":"https://clinicaltrials.gov/study/NCT07019259","title":"Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors","has_exemption":false,"start_date":"2025-06-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861439","publication_url":"https://clinicaltrials.gov/study/NCT06861439","title":"Effects of Tirzepatide on Fat-Free Mass, Bone and Physical Function in Older Adults - a Pilot Study","has_exemption":false,"start_date":"2025-07-07","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06892288","publication_url":"https://clinicaltrials.gov/study/NCT06892288","title":"A Phase 2b, Multicenter, Double-blind, Randomized, Placebo Controlled Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 Administered Intravenously to Participants With PMM2-CDG (POLAR Trial)","has_exemption":false,"start_date":"2025-07-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Glycomine, Inc.","sponsor_slug":"glycomine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973785","publication_url":"https://clinicaltrials.gov/study/NCT06973785","title":"Non-Narcotic Pain Control After ACL Reconstruction","has_exemption":false,"start_date":"2025-07-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05691244","publication_url":"https://clinicaltrials.gov/study/NCT05691244","title":"A Multicentric, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke.","has_exemption":false,"start_date":"2025-07-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Pharmazz, Inc.","sponsor_slug":"pharmazz-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06745388","publication_url":"https://clinicaltrials.gov/study/NCT06745388","title":"Evaluating the Impacts of Intravenous Magnesium Sulfate and Ketamine on Cramping Pain and Total Opioid Consumption Following Hysteroscopy: A Prospective, Randomized Trial","has_exemption":false,"start_date":"2025-07-29","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07024693","publication_url":"https://clinicaltrials.gov/study/NCT07024693","title":"A Phase 2, Multicenter, Open-Label Study to Assess the Pharmacodynamics, Safety, and Tolerability of DT-168 Ophthalmic Solution in Patients With Fuchs Endothelial Corneal Dystrophy Undergoing Keratoplasty","has_exemption":false,"start_date":"2025-07-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Design Therapeutics, Inc.","sponsor_slug":"design-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470373","publication_url":"https://clinicaltrials.gov/study/NCT06470373","title":"A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-07-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rophibio, Inc.","sponsor_slug":"rophibio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07008001","publication_url":"https://clinicaltrials.gov/study/NCT07008001","title":"Clinical Assessment of DOT Spectacle Lenses in Chinese Children Extension","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"SightGlass Vision, Inc.","sponsor_slug":"sightglass-vision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06683014","publication_url":"https://clinicaltrials.gov/study/NCT06683014","title":"The Effects of MDMA (3,4-methylenedioxymethamphetamine) in Social Cognition in Borderline Personality Disorder","has_exemption":false,"start_date":"2025-09-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06931860","publication_url":"https://clinicaltrials.gov/study/NCT06931860","title":"Comparative Effectiveness of Mailed Cologuard Outreach to Mailed FIT Outreach","has_exemption":false,"start_date":"2025-09-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06982508","publication_url":"https://clinicaltrials.gov/study/NCT06982508","title":"A Randomized, Double-Blind, Placebo-Controlled Parallel Trial to Assess the Effects of Obicetrapib on Levels of Antioxidants in Plasma and HDL Particles in Healthy Volunteers: The VERMEER Study","has_exemption":false,"start_date":"2025-09-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"NewAmsterdam Pharma","sponsor_slug":"newamsterdam-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07177417","publication_url":"https://clinicaltrials.gov/study/NCT07177417","title":"EVax-3: Human Upper and Lower Airway Mucosal Immune Response to FluMist Vaccination","has_exemption":false,"start_date":"2025-09-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301008","publication_url":"https://clinicaltrials.gov/study/NCT07301008","title":"Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US","has_exemption":false,"start_date":"2025-09-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medstar Health Research Institute","sponsor_slug":"medstar-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06419959","publication_url":"https://clinicaltrials.gov/study/NCT06419959","title":"Improving Cardiovascular Health in Veterans With PTSD by Treating Trauma-Related Nightmares With NightWare","has_exemption":false,"start_date":"2025-09-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07098715","publication_url":"https://clinicaltrials.gov/study/NCT07098715","title":"Closure Of Cryptoglandular Fistula-in-ano And Associated Non-healing Draining Wounds With Kerecis SurgiClose","has_exemption":false,"start_date":"2025-09-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06781385","publication_url":"https://clinicaltrials.gov/study/NCT06781385","title":"Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke","has_exemption":false,"start_date":"2025-09-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07049900","publication_url":"https://clinicaltrials.gov/study/NCT07049900","title":"Baby ABS (Abdominal Binder Study) : Impact of Abdominal Binder Use on Abdominal Wall Development in Premature Infants Requiring CPAP Support","has_exemption":false,"start_date":"2025-09-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07077902","publication_url":"https://clinicaltrials.gov/study/NCT07077902","title":"An Open Label Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam as a Mono or add-on Therapy in the Treatment of Hidradenitis Suppurativa With Correlative Analysis.","has_exemption":false,"start_date":"2025-09-25","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Tulane University","sponsor_slug":"tulane-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07001072","publication_url":"https://clinicaltrials.gov/study/NCT07001072","title":"Mitigating Freezing of Gait (FoG) in Parkinson's Disease With Spatiotemporal Haptic Feedback Delivered by Smartshoes","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07194642","publication_url":"https://clinicaltrials.gov/study/NCT07194642","title":"Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized Nutrition","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222826","publication_url":"https://clinicaltrials.gov/study/NCT07222826","title":"Non-invasive Intracranial Pressure Estimation by Measurement of the Occlusion Pressure of the Isolated Periorbital Vein (NICE-ICP)","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Compremium AG","sponsor_slug":"compremium-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07152717","publication_url":"https://clinicaltrials.gov/study/NCT07152717","title":"Assessment of a Connected-health, Pressure Monitoring Technology for Improving Clinical Outcomes of Compression Therapy in the Treatment of Venous Leg Ulcers","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Feeltect Limited","sponsor_slug":"feeltect-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209683","publication_url":"https://clinicaltrials.gov/study/NCT07209683","title":"Age-specific Neurovascular Effects of Transcranial Photobiomodulation","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07500532","publication_url":"https://clinicaltrials.gov/study/NCT07500532","title":"Evaluation of the Medentum Diagnostik Platform for Pediatric ENT Conditions and Asthma","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Medentum Innovations","sponsor_slug":"medentum-innovations","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07033481","publication_url":"https://clinicaltrials.gov/study/NCT07033481","title":"A Phase 2a Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Primary Progressive Aphasia (PPA)","has_exemption":false,"start_date":"2025-10-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"EIP Pharma Inc","sponsor_slug":"eip-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07407920","publication_url":"https://clinicaltrials.gov/study/NCT07407920","title":"Optimization of Adjuvant Systemic Therapy in Patients With Early HER2-Positive (HER2+) Breast Cancer or Triple Negative Breast Cancer (TNBC) That Achieved a Pathological Complete Response (pCR) After Neoadjuvant Systemic Therapy and Do Not Have Molecular Residual Disease (MRD-Negative): A Phase II Clinical Trial (The MolecularPCR Trial)","has_exemption":false,"start_date":"2025-10-09","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084818","publication_url":"https://clinicaltrials.gov/study/NCT07084818","title":"Enabling Self-Care for Pessary Users in Rural Setting","has_exemption":false,"start_date":"2025-10-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07251140","publication_url":"https://clinicaltrials.gov/study/NCT07251140","title":"Novel Acoustic Biopatch for the Investigation of Dysphagia","has_exemption":false,"start_date":"2025-10-12","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07144631","publication_url":"https://clinicaltrials.gov/study/NCT07144631","title":"PENS-P: Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome (RLS)","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07074977","publication_url":"https://clinicaltrials.gov/study/NCT07074977","title":"An Exploratory Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics (PK/PD) of Nemolizumab in Adult Participants With Chronic Pruritus of Unknown Origin (CPUO)","has_exemption":false,"start_date":"2025-10-20","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07153939","publication_url":"https://clinicaltrials.gov/study/NCT07153939","title":"Multicenter Pivotal Study of the Velocity™ Percutaneous Arterio-Venous Fistula System","has_exemption":false,"start_date":"2025-10-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Venova Medical","sponsor_slug":"venova-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07399028","publication_url":"https://clinicaltrials.gov/study/NCT07399028","title":"A Single-center, Open-label Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging","has_exemption":false,"start_date":"2025-10-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06808451","publication_url":"https://clinicaltrials.gov/study/NCT06808451","title":"Diagnosis and Treatment of Urinary Tract Infection Using DNA PCR Versus Urine Culture - A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-22","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213921","publication_url":"https://clinicaltrials.gov/study/NCT07213921","title":"Intraoperative Dermabrasion in Mohs Surgery: A Randomized Split-Scar Trial","has_exemption":false,"start_date":"2025-10-23","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216599","publication_url":"https://clinicaltrials.gov/study/NCT07216599","title":"Photoacoustic Imaging in Wound Evaluation and Treatment Guidance","has_exemption":false,"start_date":"2025-10-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990984","publication_url":"https://clinicaltrials.gov/study/NCT06990984","title":"A Phase 2a Partially Randomized, Placebo-controlled, Sequential Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Thiogenesis Therapeutics, Inc.","sponsor_slug":"thiogenesis-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07179055","publication_url":"https://clinicaltrials.gov/study/NCT07179055","title":"An Eight-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300917","publication_url":"https://clinicaltrials.gov/study/NCT07300917","title":"Efficacy and Safety of a 1726-nm Sebaceous-Targeting Diode Laser for the Treatment of Fordyce Spots of the Lips: A Prospective Pilot Study","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Venus Research Center","sponsor_slug":"venus-research-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281495","publication_url":"https://clinicaltrials.gov/study/NCT07281495","title":"A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study With Open-Label Extension to Assess the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Taldefgrobep Alfa in Adults Living With Overweight and Obesity","has_exemption":false,"start_date":"2025-11-24","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020611","publication_url":"https://clinicaltrials.gov/study/NCT07020611","title":"Aneurysm SaC ManagemENt Device for Abdominal Aortic Aneurysms First-in-Human (ASCEND) Study","has_exemption":false,"start_date":"2025-11-26","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Life Seal Vascular Inc.","sponsor_slug":"life-seal-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216014","publication_url":"https://clinicaltrials.gov/study/NCT07216014","title":"Analysis of the Efficacy and Safety of Interleukin-23 Monoclonal Antibody in Inflammatory Bowel Disease: A Prospective Study","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","sponsor_slug":"sixth-affiliated-hospital-sun-yat-sen-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400588","publication_url":"https://clinicaltrials.gov/study/NCT07400588","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Study of the Safety and Tolerability of Aleniglipron in Adult Participants With Type 2 Diabetes Mellitus Living With Obesity or Overweight","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics","sponsor_slug":"gasherbrum-bio-inc-a-wholly-owned-subsidiary-of-structure-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161765","publication_url":"https://clinicaltrials.gov/study/NCT07161765","title":"Rectal Evacuation Disorders and Straining-associated Symptoms in Bleeding Hemorrhoids","has_exemption":false,"start_date":"2025-12-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400965","publication_url":"https://clinicaltrials.gov/study/NCT07400965","title":"Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis","has_exemption":false,"start_date":"2025-12-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06904911","publication_url":"https://clinicaltrials.gov/study/NCT06904911","title":"Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy","has_exemption":false,"start_date":"2025-12-11","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221513","publication_url":"https://clinicaltrials.gov/study/NCT07221513","title":"A Phase 2a, Open-Label Study to Assess the Safety, Tolerability, and Efficacy of JK07 in Participants With Heart Failure and Group 2 Combined Post-Capillary and Pre-Capillary Pulmonary Hypertension (RENEU-PH)","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Salubris Biotherapeutics Inc","sponsor_slug":"salubris-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05459181","publication_url":"https://clinicaltrials.gov/study/NCT05459181","title":"Molecular Outcome Surveillance Using AlloSure and AlloMap Guided Immunomodulation in Cardiac Transplant","has_exemption":false,"start_date":"2025-12-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"CareDx","sponsor_slug":"caredx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209085","publication_url":"https://clinicaltrials.gov/study/NCT07209085","title":"SPARC: A Prospective, Multicenter Evaluation of the Safety and Performance of the Artero Intravascular Lithotripsy System for the Treatment of Peripheral Artery Disease and Remodeling Arterial Calcium","has_exemption":false,"start_date":"2025-12-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"FastWave Medical","sponsor_slug":"fastwave-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07313930","publication_url":"https://clinicaltrials.gov/study/NCT07313930","title":"A Single-Center, Prospective, Randomized, Controlled Study Comparing Intraoperative and Perioperative Outcomes Using the CONMED AirSeal® and Lexicon Insufflators During Laparoscopic Sleeve Gastrectomy.","has_exemption":false,"start_date":"2026-01-10","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"SurgiQuest, Inc.","sponsor_slug":"surgiquest-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07235293","publication_url":"https://clinicaltrials.gov/study/NCT07235293","title":"A Randomized, Open-label, Phase 2b Study to Compare the Efficacy of DSP107 in Combination With Atezolizumab Versus Fruquintinib in Patients With Advanced Microsatellite Stable Colorectal Cancer","has_exemption":false,"start_date":"2026-01-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Kahr Bio Australia Pty Ltd","sponsor_slug":"kahr-bio-australia-pty-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276373","publication_url":"https://clinicaltrials.gov/study/NCT07276373","title":"A Phase 1b/2, Open-Label, Dose-Finding and Proof of Concept Study of Nenocorilant in Combination With Anti-Programmed Cell Death/(Ligand) 1 in Patients With Advanced Solid Malignancies","has_exemption":false,"start_date":"2026-01-16","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07316192","publication_url":"https://clinicaltrials.gov/study/NCT07316192","title":"Outcomes With Pelashield™ PainGuard™ Compared to Restrata® in Standard Two-Stage Excision and Closure for Hidradenitis Suppurativa: A Prospective Cohort With Retrospective Comparator","has_exemption":false,"start_date":"2026-01-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07243275","publication_url":"https://clinicaltrials.gov/study/NCT07243275","title":"Comparing the Efficacy of SYSTANE® PRO to MIEBO™ for the Treatment of Dry Eye Disease","has_exemption":false,"start_date":"2026-02-18","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06871150","publication_url":"https://clinicaltrials.gov/study/NCT06871150","title":"Surgical Management and Advanced Real Time Technologies for Fluid Optimization in Major Abdominal Surgery: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-03-02","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"ASST Sette Laghi","sponsor_slug":"asst-sette-laghi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449416","publication_url":"https://clinicaltrials.gov/study/NCT07449416","title":"Ceribell Delirium Monitor Outcomes Pilot Study","has_exemption":false,"start_date":"2026-03-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Ceribell Inc.","sponsor_slug":"ceribell-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07453914","publication_url":"https://clinicaltrials.gov/study/NCT07453914","title":"Clinical Assessment of Respiratory Events for Kids: Integrating Diagnostics and Stewardship","has_exemption":false,"start_date":"2026-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"BioMérieux","sponsor_slug":"biomerieux","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07490535","publication_url":"https://clinicaltrials.gov/study/NCT07490535","title":"Single-Center, Open-Label Trial to Evaluate the Effect of Lifitegrast Ophthalmic Solution 5.0% on Tear Film Biomarkers in Dry Eye Disease","has_exemption":false,"start_date":"2026-03-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Pittsburgh Research Institute","sponsor_slug":"pittsburgh-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07414771","publication_url":"https://clinicaltrials.gov/study/NCT07414771","title":"A Medical Device Pilot Study to Evaluate the Safety and Usability of the Inga Catheter in Labor Induction","has_exemption":false,"start_date":"2026-04-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Aalto University","sponsor_slug":"aalto-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07501676","publication_url":"https://clinicaltrials.gov/study/NCT07501676","title":"Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief","has_exemption":false,"start_date":"2026-04-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07176286","publication_url":"https://clinicaltrials.gov/study/NCT07176286","title":"An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F-mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With and Without Lewy Body Diseases","has_exemption":false,"start_date":"2026-04-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)","sponsor_slug":"innervate-radiopharmaceuticals-llc-formerly-illumina-radiopharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05379153","publication_url":"https://clinicaltrials.gov/study/NCT05379153","title":"The Revitalize Trial: Reducing Vaginal Atrophy With Fractional CO2 Laser for Breast Cancer Survivors","has_exemption":false,"start_date":"2026-04-21","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325578","publication_url":"https://clinicaltrials.gov/study/NCT07325578","title":"Evaluation of the Epione Robotic System for Image-guided Percutaneous MSK Procedures of the Pelvis and Spine in USA. A Prospective Study on Feasibility, Safety and Accuracy","has_exemption":false,"start_date":"2026-04-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Precision IO Group","sponsor_slug":"precision-io-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07116902","publication_url":"https://clinicaltrials.gov/study/NCT07116902","title":"Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes: A Digital Twin Study","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228052","publication_url":"https://clinicaltrials.gov/study/NCT07228052","title":"Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department: A Randomized Control Trial","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07335484","publication_url":"https://clinicaltrials.gov/study/NCT07335484","title":"Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Axonics External Trial System (ETS-02)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Axonics, Inc.","sponsor_slug":"axonics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07508488","publication_url":"https://clinicaltrials.gov/study/NCT07508488","title":"Deucravacitinib in the Treatment of Cicatricial Alopecias","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07560735","publication_url":"https://clinicaltrials.gov/study/NCT07560735","title":"Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy (IVCM)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Toyos Clinic","sponsor_slug":"toyos-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07432282","publication_url":"https://clinicaltrials.gov/study/NCT07432282","title":"Early Feasibility Study on the Safety and Performance of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening With the INGA Balloon Catheter","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Aalto University","sponsor_slug":"aalto-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07551596","publication_url":"https://clinicaltrials.gov/study/NCT07551596","title":"A Phase 2 Study of Microsatellite Stable Colorectal Cancer (Stage 2 or 3) With Radiographic Occult Molecular Residual Disease Treated With Botensilimab (AGEN1181; Bot) Plus Balstilimab (AGEN2034, Bal) After Established Definitive Therapy (COMBAT Study)","has_exemption":false,"start_date":"2026-05-28","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07068243","publication_url":"https://clinicaltrials.gov/study/NCT07068243","title":"Transverse Versus Longitudinal Approaches for Rectus Sheath Block: a Randomized Controlled Trial in Healthy Volunteers","has_exemption":false,"start_date":"2026-05-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07435077","publication_url":"https://clinicaltrials.gov/study/NCT07435077","title":"Examining Analgesic Synergy and Efficacy in Trauma Care-A Randomized, Control Study of Buprenorphine Versus Oxycodone in Multimodal Pain Control Regimens","has_exemption":false,"start_date":"2026-05-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565480","publication_url":"https://clinicaltrials.gov/study/NCT07565480","title":"Collection of Training Data for LuminX Probe AI Models","has_exemption":false,"start_date":"2026-05-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"LuminX","sponsor_slug":"luminx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06073808","publication_url":"https://clinicaltrials.gov/study/NCT06073808","title":"The Role of Amnion Membrane Allografts in Nipple Preservation After Nipple Sparing Mastectomy: A Double-Blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2026-06-01","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07503561","publication_url":"https://clinicaltrials.gov/study/NCT07503561","title":"A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Operationally Seamless Phase 2/3 Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of AIC263029 in the Treatment of BKV Infection in Kidney Transplant Recipients","has_exemption":false,"start_date":"2026-06-15","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"AiCuris Anti-infective Cures AG","sponsor_slug":"aicuris-anti-infective-cures-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06977633","publication_url":"https://clinicaltrials.gov/study/NCT06977633","title":"A pH-Responsive Hydrogel Microneedle Patch for Continuous Measurement of Ketone Bodies and Glucose: CGM-CKM","has_exemption":false,"start_date":"2026-06-30","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Mahla Poudineh","sponsor_slug":"mahla-poudineh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281638","publication_url":"https://clinicaltrials.gov/study/NCT07281638","title":"Bedside Bike Early Mobilization Program for Inpatients","has_exemption":false,"start_date":"2026-07-05","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06701461","publication_url":"https://clinicaltrials.gov/study/NCT06701461","title":"Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals","has_exemption":false,"start_date":"2026-08-31","completion_date":"2026-09-30","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02118467","publication_url":"https://clinicaltrials.gov/study/NCT02118467","title":"A Randomized Double Blind Trial of Vasoactive Drugs for the Management of Shock in the ICU","has_exemption":false,"start_date":"2014-05-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02605421","publication_url":"https://clinicaltrials.gov/study/NCT02605421","title":"Tandem Myeloablative Consolidation Therapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma","has_exemption":false,"start_date":"2016-06-30","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03224767","publication_url":"https://clinicaltrials.gov/study/NCT03224767","title":"Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas","has_exemption":false,"start_date":"2018-01-05","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03672773","publication_url":"https://clinicaltrials.gov/study/NCT03672773","title":"A Phase 2 Study of Continuous Talazoparib Plus Intermittent Low-Dose Temozolomide in Patients With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer (TRIO-US L-07)","has_exemption":false,"start_date":"2018-10-31","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04071223","publication_url":"https://clinicaltrials.gov/study/NCT04071223","title":"A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis (RadiCal)","has_exemption":false,"start_date":"2020-07-29","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04339777","publication_url":"https://clinicaltrials.gov/study/NCT04339777","title":"A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity","has_exemption":false,"start_date":"2020-09-22","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04161534","publication_url":"https://clinicaltrials.gov/study/NCT04161534","title":"KT Tape vs Arm Sling for Pediatric Clavicle Fractures","has_exemption":false,"start_date":"2020-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04210089","publication_url":"https://clinicaltrials.gov/study/NCT04210089","title":"Total Contact Soft Cast in Diabetic Foot Ulcers","has_exemption":false,"start_date":"2020-10-13","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04548752","publication_url":"https://clinicaltrials.gov/study/NCT04548752","title":"Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients With Germline BRCA1 or BRCA2 Mutations","has_exemption":false,"start_date":"2021-02-22","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05357040","publication_url":"https://clinicaltrials.gov/study/NCT05357040","title":"Evaluation of the Antidepressant Effects of Nitrous Oxide in People With Major Depressive Disorder","has_exemption":false,"start_date":"2021-06-30","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04550728","publication_url":"https://clinicaltrials.gov/study/NCT04550728","title":"Assessment Followed by Home-based Hybrid Robot + FES Rehabilitation Post-stroke","has_exemption":false,"start_date":"2021-08-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04722029","publication_url":"https://clinicaltrials.gov/study/NCT04722029","title":"Open-Label Pilot Study of Haploidentical Donor Adenovirus Specific T Lymphocytes (ADV-VSTS) for the Treatment of Refractory Adenovirus Infection and/or Disease in Hospitalized Patients","has_exemption":false,"start_date":"2021-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05038527","publication_url":"https://clinicaltrials.gov/study/NCT05038527","title":"ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery - a Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2021-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Rigshospitalet, Denmark","sponsor_slug":"rigshospitalet-denmark","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04486352","publication_url":"https://clinicaltrials.gov/study/NCT04486352","title":"A Phase IB/II Multi-Cohort Study of Targeted Agents and/or Immunotherapy With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer","has_exemption":false,"start_date":"2021-10-20","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Alliance Foundation Trials, LLC.","sponsor_slug":"alliance-foundation-trials-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04812925","publication_url":"https://clinicaltrials.gov/study/NCT04812925","title":"A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia","has_exemption":false,"start_date":"2021-11-17","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230537","publication_url":"https://clinicaltrials.gov/study/NCT05230537","title":"A Randomized, Participant and Investigator Masked, Placebo-controlled, Multicenter, Proof-of-concept Study to Assess the Safety and Efficacy of LNP023 (Iptacopan) in Patients With Early and Intermediate Age-related Macular Degeneration","has_exemption":false,"start_date":"2022-02-17","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04577755","publication_url":"https://clinicaltrials.gov/study/NCT04577755","title":"A Multicenter Phase II Study of Pomalidomide Monotherapy in Kaposi Sarcoma","has_exemption":false,"start_date":"2022-03-18","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05368844","publication_url":"https://clinicaltrials.gov/study/NCT05368844","title":"Harnessing Neurostimulation to Improve Treatment Outcome in Anorexia Nervosa","has_exemption":false,"start_date":"2022-06-16","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05467800","publication_url":"https://clinicaltrials.gov/study/NCT05467800","title":"A Phase 2 Study of Canakinumab in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium [MPN-RC 122]","has_exemption":false,"start_date":"2022-08-02","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"John Mascarenhas","sponsor_slug":"john-mascarenhas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05417776","publication_url":"https://clinicaltrials.gov/study/NCT05417776","title":"Collagen-targeted PET Imaging for Early Interstitial Lung Disease","has_exemption":false,"start_date":"2022-09-28","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05361720","publication_url":"https://clinicaltrials.gov/study/NCT05361720","title":"Optimal Treatment by Invoking Biologic Clusters in Renal Cell Carcinoma (OPTIC RCC)","has_exemption":false,"start_date":"2022-12-06","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05558904","publication_url":"https://clinicaltrials.gov/study/NCT05558904","title":"Positron-Emission Tomography Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer","has_exemption":false,"start_date":"2023-01-19","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04682652","publication_url":"https://clinicaltrials.gov/study/NCT04682652","title":"GRAVITY: Genicular Artery Embolization Versus Observation for the Treatment of Symptomatic Knee Osteoarthritis: a Randomized Controlled Trial","has_exemption":false,"start_date":"2023-08-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05642455","publication_url":"https://clinicaltrials.gov/study/NCT05642455","title":"A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"USWM CT, LLC","sponsor_slug":"uswm-ct-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04713046","publication_url":"https://clinicaltrials.gov/study/NCT04713046","title":"A Phase I Clinical Trial Assessing the Safety, Feasibility and Immunologic Correlates of Allogeneic HPV-specific Cluster of Differentiation 4 (CD4)+ T Cells in Advanced HPV16-associated Malignancies","has_exemption":false,"start_date":"2023-10-18","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052176","publication_url":"https://clinicaltrials.gov/study/NCT06052176","title":"Randomized Clinical Trial in Hepatic Encephalopathy to Study Lasting Cognitive Improvement With Intravenous Albumin","has_exemption":false,"start_date":"2023-11-02","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Hunter Holmes Mcguire Veteran Affairs Medical Center","sponsor_slug":"hunter-holmes-mcguire-veteran-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095063","publication_url":"https://clinicaltrials.gov/study/NCT06095063","title":"Effect of Deep Transcranial Magnetic Stimulation (dTMS) on Cognition in Older Adults With Subjective Cognitive Decline (SCD)","has_exemption":false,"start_date":"2023-11-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Rotman Research Institute at Baycrest","sponsor_slug":"rotman-research-institute-at-baycrest","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05974488","publication_url":"https://clinicaltrials.gov/study/NCT05974488","title":"The Efficacy of Distal Pharyngeal Airway in Enhancing Oxygenation During Transesophageal Echocardiography (TEE) in Patients Sedated With Propofol","has_exemption":false,"start_date":"2023-11-30","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05999812","publication_url":"https://clinicaltrials.gov/study/NCT05999812","title":"Phase II Single-arm, Single-center Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Refractory Microsatellite Stable Colorectal Cancer","has_exemption":false,"start_date":"2023-12-19","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564403","publication_url":"https://clinicaltrials.gov/study/NCT05564403","title":"FOLFOX in Combination With Binimetinib as 2nd Line Therapy for Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations: A ComboMATCH Treatment Trial","has_exemption":false,"start_date":"2024-02-09","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05783323","publication_url":"https://clinicaltrials.gov/study/NCT05783323","title":"Larotrectinib to Enhance RAI Avidity in Patients With Differentiated Thyroid Cancer Harboring NTRK Fusions (LANTERN)","has_exemption":false,"start_date":"2024-02-14","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06200207","publication_url":"https://clinicaltrials.gov/study/NCT06200207","title":"Effects of Ziltivekimab Versus Placebo on Heart Failure Symptoms and Physical Function in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06724146","publication_url":"https://clinicaltrials.gov/study/NCT06724146","title":"Safety and Efficacy of Upper Arm Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance","has_exemption":false,"start_date":"2024-08-05","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Sofwave Medical LTD","sponsor_slug":"sofwave-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284564","publication_url":"https://clinicaltrials.gov/study/NCT06284564","title":"A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)","has_exemption":false,"start_date":"2024-08-07","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06551402","publication_url":"https://clinicaltrials.gov/study/NCT06551402","title":"Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis, a Randomized Controlled Trial","has_exemption":false,"start_date":"2024-08-09","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06278987","publication_url":"https://clinicaltrials.gov/study/NCT06278987","title":"Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06530524","publication_url":"https://clinicaltrials.gov/study/NCT06530524","title":"Pretherapy Botulinum Toxin to Reduce Radiation-related Xerostomia in Head and Neck Cancer","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Sir Mortimer B. Davis - Jewish General Hospital","sponsor_slug":"sir-mortimer-b-davis-jewish-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06570590","publication_url":"https://clinicaltrials.gov/study/NCT06570590","title":"A Prospective Study of the Minimally Invasive Lapidus Procedure for Hallux Valgus Deformities Randomized With Arthroscopy or No Arthroscopy at St. Paul's Hospital in Vancouver, Canada","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"St. Paul's Hospital, Canada","sponsor_slug":"st-pauls-hospital-canada","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07556367","publication_url":"https://clinicaltrials.gov/study/NCT07556367","title":"Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947955","publication_url":"https://clinicaltrials.gov/study/NCT05947955","title":"A Phase 2 Randomized Double-blind Placebo-controlled Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard Care For Moderate-to-Severe ARDS Due To Pneumonia Or Other Infections","has_exemption":false,"start_date":"2024-10-03","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"BioAegis Therapeutics Inc.","sponsor_slug":"bioaegis-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06427226","publication_url":"https://clinicaltrials.gov/study/NCT06427226","title":"Clinical Study to Evaluate the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients","has_exemption":false,"start_date":"2024-10-31","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06374147","publication_url":"https://clinicaltrials.gov/study/NCT06374147","title":"\"Prapela® SVS Incubator Pad: a Cost-effective Stochastic Vibrotactile Device to Improve the Clinical Course of Infants with Apnea of Prematurity.\"","has_exemption":false,"start_date":"2025-02-06","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Tufts Medical Center","sponsor_slug":"tufts-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06811272","publication_url":"https://clinicaltrials.gov/study/NCT06811272","title":"A Phase 2 Study of Outpatient Epcoritamab as Second Line Therapy in Non-Transplant Eligible Relapsed/Refractory Large B-cell Lymphoma","has_exemption":false,"start_date":"2025-06-05","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06409819","publication_url":"https://clinicaltrials.gov/study/NCT06409819","title":"Phase 1/ 2 Trial of Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044362","publication_url":"https://clinicaltrials.gov/study/NCT07044362","title":"Histotripsy Plus Chemotherapy for Advanced Colorectal Liver Metastasis: A Prospective, Single-Armed Trial","has_exemption":false,"start_date":"2025-06-30","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05639972","publication_url":"https://clinicaltrials.gov/study/NCT05639972","title":"A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers","has_exemption":false,"start_date":"2025-08-11","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Christian Hinrichs","sponsor_slug":"christian-hinrichs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06479824","publication_url":"https://clinicaltrials.gov/study/NCT06479824","title":"NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study","has_exemption":false,"start_date":"2025-08-19","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06742307","publication_url":"https://clinicaltrials.gov/study/NCT06742307","title":"Faricimab Fixed Quarterly Maintenance for Neovascular Age Related Macular Degeneration: A Prospective Case Series","has_exemption":false,"start_date":"2025-08-21","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Authority, Hong Kong","sponsor_slug":"hospital-authority-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217223","publication_url":"https://clinicaltrials.gov/study/NCT07217223","title":"Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study","has_exemption":false,"start_date":"2025-09-27","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07197203","publication_url":"https://clinicaltrials.gov/study/NCT07197203","title":"Comparison of Caudal Block and Sacral Erector Spinae Plane Block With Dexmedetomidine in Pediatric Penile Hypospadias Repair","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07177326","publication_url":"https://clinicaltrials.gov/study/NCT07177326","title":"Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07119268","publication_url":"https://clinicaltrials.gov/study/NCT07119268","title":"SPARK-Healthy Sleep: A Digital Health Intervention to Promote Behavioral, Emotional, and Cognitive Changes","has_exemption":false,"start_date":"2025-10-24","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07168525","publication_url":"https://clinicaltrials.gov/study/NCT07168525","title":"Effects of Ultrasound on Healthy Aging","has_exemption":false,"start_date":"2025-10-29","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325188","publication_url":"https://clinicaltrials.gov/study/NCT07325188","title":"Clinical Evaluation of a Novel Intraoperative Guidance System for Accurate Toric IOL Positioning in Cataract Surgery","has_exemption":false,"start_date":"2025-11-04","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Gainesville Eye Associates","sponsor_slug":"gainesville-eye-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184983","publication_url":"https://clinicaltrials.gov/study/NCT07184983","title":"Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction Recovery Enhancement Stimulation) Initiative","has_exemption":false,"start_date":"2025-11-12","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07123090","publication_url":"https://clinicaltrials.gov/study/NCT07123090","title":"A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma - SPARCC","has_exemption":false,"start_date":"2025-11-24","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Stephanie Berg","sponsor_slug":"stephanie-berg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06590454","publication_url":"https://clinicaltrials.gov/study/NCT06590454","title":"Therapeutic Intervention to Reverse Gastric Precancer","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Katherine Garman","sponsor_slug":"katherine-garman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011147","publication_url":"https://clinicaltrials.gov/study/NCT07011147","title":"Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery","has_exemption":false,"start_date":"2026-01-16","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07040397","publication_url":"https://clinicaltrials.gov/study/NCT07040397","title":"Comparing an Electronic Approach to the Human Massage Therapist.","has_exemption":false,"start_date":"2026-01-30","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07198139","publication_url":"https://clinicaltrials.gov/study/NCT07198139","title":"A Phase 1b, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Norovirus","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Cocrystal Pharma, Inc.","sponsor_slug":"cocrystal-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07496463","publication_url":"https://clinicaltrials.gov/study/NCT07496463","title":"Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512206","publication_url":"https://clinicaltrials.gov/study/NCT07512206","title":"AERO CAD: A Prospective, Multi-Center, Single-Arm Study Evaluating the Shockwave C2 Aero Coronary IVL System in Calcified Coronary Artery Disease","has_exemption":false,"start_date":"2026-04-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"OPCI Core Laboratories LLC","sponsor_slug":"opci-core-laboratories-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07532876","publication_url":"https://clinicaltrials.gov/study/NCT07532876","title":"Comparison of Efficacy and Safety of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-10-01","has_results":false,"results_due":false,"sponsor_name":"Pak Emirates Military Hospital","sponsor_slug":"pak-emirates-military-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04561206","publication_url":"https://clinicaltrials.gov/study/NCT04561206","title":"A Phase 2 Study of Brentuximab Vedotin Plus Nivolumab Without Stem Cell Consolidation in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma","has_exemption":false,"start_date":"2021-11-12","completion_date":"2026-10-02","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07363720","publication_url":"https://clinicaltrials.gov/study/NCT07363720","title":"A Double-blind, Placebo-Controlled, Randomized Withdrawal Trial to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)","has_exemption":false,"start_date":"2026-01-29","completion_date":"2026-10-02","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03869372","publication_url":"https://clinicaltrials.gov/study/NCT03869372","title":"Cerebral Cortical Influences on Autonomic Function","has_exemption":false,"start_date":"2019-04-05","completion_date":"2026-10-03","has_results":false,"results_due":false,"sponsor_name":"David Levinthal","sponsor_slug":"david-levinthal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03165734","publication_url":"https://clinicaltrials.gov/study/NCT03165734","title":"A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Count <50,000/μL)(PACIFICA)","has_exemption":false,"start_date":"2017-06-26","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"Swedish Orphan Biovitrum","sponsor_slug":"swedish-orphan-biovitrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05164094","publication_url":"https://clinicaltrials.gov/study/NCT05164094","title":"A Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults","has_exemption":false,"start_date":"2021-12-28","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05511363","publication_url":"https://clinicaltrials.gov/study/NCT05511363","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease","has_exemption":false,"start_date":"2022-08-23","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06863961","publication_url":"https://clinicaltrials.gov/study/NCT06863961","title":"A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Patients With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574101","publication_url":"https://clinicaltrials.gov/study/NCT05574101","title":"A Phase II, Multicenter, Single-Arm Clinical Trial of Radiotherapy and CeMiPlimAb: Rwlc ImmunoTherapy for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: RAMPART","has_exemption":false,"start_date":"2022-10-06","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003426","publication_url":"https://clinicaltrials.gov/study/NCT06003426","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2023-09-14","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04568837","publication_url":"https://clinicaltrials.gov/study/NCT04568837","title":"Postoperative Steroids and Recovery After Spine Fusion","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298382","publication_url":"https://clinicaltrials.gov/study/NCT07298382","title":"See the Impact Beem's Blue Light Therapy Has on Your Skin Health!","has_exemption":false,"start_date":"2025-10-06","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02612454","publication_url":"https://clinicaltrials.gov/study/NCT02612454","title":"An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients ≥6 Months to <18 Years of Age With Atopic Dermatitis","has_exemption":false,"start_date":"2015-10-15","completion_date":"2026-10-07","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07215104","publication_url":"https://clinicaltrials.gov/study/NCT07215104","title":"A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) for the Treatment of Chronic Low Back Pain","has_exemption":false,"start_date":"2025-10-07","completion_date":"2026-10-07","has_results":false,"results_due":false,"sponsor_name":"Saint Francis Hospital","sponsor_slug":"saint-francis-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090358","publication_url":"https://clinicaltrials.gov/study/NCT05090358","title":"Targeting Insulin Feedback to Enhance Alpelisib (TIFA): A Phase 2 Randomized Control Trial in Metastatic PIK3CA-mutant Hormone-Receptor Positive Breast Cancer","has_exemption":false,"start_date":"2021-10-08","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06332040","publication_url":"https://clinicaltrials.gov/study/NCT06332040","title":"A Randomized Controlled Trial to Evaluate the Effectiveness of Gentamicin Bladder Instillation on CAUTI","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","sponsor_slug":"st-josephs-hospital-and-medical-center-phoenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616194","publication_url":"https://clinicaltrials.gov/study/NCT06616194","title":"AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE","has_exemption":false,"start_date":"2024-11-15","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05202782","publication_url":"https://clinicaltrials.gov/study/NCT05202782","title":"Phase II, Single-Arm, Open-label, Multicenter Study Evaluating the Efficacy of Adjunctive Zanubrutinib and CAR T-Cell Therapy in Aggressive B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2022-03-21","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616974","publication_url":"https://clinicaltrials.gov/study/NCT06616974","title":"A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)","has_exemption":false,"start_date":"2024-09-04","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Tectonic Therapeutic","sponsor_slug":"tectonic-therapeutic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06958211","publication_url":"https://clinicaltrials.gov/study/NCT06958211","title":"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-12","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959225","publication_url":"https://clinicaltrials.gov/study/NCT06959225","title":"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-23","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05367245","publication_url":"https://clinicaltrials.gov/study/NCT05367245","title":"Microbiome Targeted Oral Butyrate Therapy in Gulf War Multisymptom Illness","has_exemption":false,"start_date":"2024-01-15","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976697","publication_url":"https://clinicaltrials.gov/study/NCT06976697","title":"Safety And Efficacy of Remotely Supervised Home-Based tDCS Treatment Of Major Depressive Disorder","has_exemption":false,"start_date":"2025-06-27","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Sooma Medical Inc","sponsor_slug":"sooma-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07193459","publication_url":"https://clinicaltrials.gov/study/NCT07193459","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of HDM1002 Tablets in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise Only","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","sponsor_slug":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092137","publication_url":"https://clinicaltrials.gov/study/NCT07092137","title":"Nano-crystalline Megestrol Acetate for Anorexia-Cachexia in Advanced Lung Cancer: A Randomized, Double-Blind, Multicenter Study","has_exemption":false,"start_date":"2025-10-10","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Guangzhou Institute of Respiratory Disease","sponsor_slug":"guangzhou-institute-of-respiratory-disease","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293611","publication_url":"https://clinicaltrials.gov/study/NCT07293611","title":"Prospective, Multicenter, Single-arm, Open-label Study to Assess the Safety and Feasibility of the Levita Magnetic Surgical System for Reduced Port in Upper Gastrointestinal Laparoscopic Procedures","has_exemption":false,"start_date":"2026-03-23","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Levita Magnetics","sponsor_slug":"levita-magnetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03821792","publication_url":"https://clinicaltrials.gov/study/NCT03821792","title":"A Phase 2 Course Determining Study for Men With Hormone-Naïve Metastatic Prostate Cancer (HNMPCa)","has_exemption":false,"start_date":"2019-07-22","completion_date":"2026-10-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05696184","publication_url":"https://clinicaltrials.gov/study/NCT05696184","title":"Pathophysiology of Pharyngo-esophageal Junction and Esophageal Mechanisms Preventing Pharyngeal Reflux of Gastric Content","has_exemption":false,"start_date":"2013-11-01","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05133531","publication_url":"https://clinicaltrials.gov/study/NCT05133531","title":"A Randomized, Open-Label, C5 Inhibitor-Controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Complement Inhibitor Treatment-Naive or Have Not Recently Received Complement Inhibitor Therapy","has_exemption":false,"start_date":"2022-08-01","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05372354","publication_url":"https://clinicaltrials.gov/study/NCT05372354","title":"An Exploratory Phase 1b/2a Multicenter, Open-Label, Novel-Novel Combination Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of CC-92480 (BMS-986348) in Novel Therapeutic Combinations in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-10-18","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05884398","publication_url":"https://clinicaltrials.gov/study/NCT05884398","title":"A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide With Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) Following PSA Response in Participants With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)","has_exemption":false,"start_date":"2023-08-31","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523412","publication_url":"https://clinicaltrials.gov/study/NCT07523412","title":"Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft. (A Randomized Controlled Clinical Study)","has_exemption":false,"start_date":"2026-04-12","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04998396","publication_url":"https://clinicaltrials.gov/study/NCT04998396","title":"A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene","has_exemption":false,"start_date":"2021-09-08","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"Aspa Therapeutics","sponsor_slug":"aspa-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389215","publication_url":"https://clinicaltrials.gov/study/NCT05389215","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2022-07-29","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"Daewoong Pharmaceutical Co. LTD.","sponsor_slug":"daewoong-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06521567","publication_url":"https://clinicaltrials.gov/study/NCT06521567","title":"Phase 1/2 Dose Determination and Dose Expansion Study of Cobolimab in Combination With Dostarlimab in Pediatric and Young Adult Participants With Newly Diagnosed and Relapsed/Refractory Tumors (POPSTAR)","has_exemption":false,"start_date":"2025-03-06","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03707340","publication_url":"https://clinicaltrials.gov/study/NCT03707340","title":"A Feasibility Study of Flibanserin in Breast Cancer Survivors on Tamoxifen and Aromatase Inhibitors","has_exemption":false,"start_date":"2018-09-14","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847724","publication_url":"https://clinicaltrials.gov/study/NCT06847724","title":"A Randomized, Double-blind, Parallel-group Study to Compare the Pharmacokinetics, Efficacy, Pharmacodynamics, Safety, and Immunogenicity of CYB704 (Proposed Ocrelizumab Biosimilar) and Ocrevus® in Participants With Relapsing Multiple Sclerosis (RMS) [STRIVE-MS].","has_exemption":false,"start_date":"2025-06-10","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"Sandoz","sponsor_slug":"sandoz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03368742","publication_url":"https://clinicaltrials.gov/study/NCT03368742","title":"A Randomized, Controlled, Open-label, Single-ascending Dose, Phase I/II Study to Investigate the Safety and Tolerability, and Efficacy of Intravenous SGT-001 in Male Adolescents and Children With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2017-12-06","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Solid Biosciences Inc.","sponsor_slug":"solid-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04144894","publication_url":"https://clinicaltrials.gov/study/NCT04144894","title":"The Biosonographic Index - A Novel Index for the Early Detection of Acute Kidney Injury After Vascular Surgery - an Exploratory Study.","has_exemption":false,"start_date":"2020-01-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04850599","publication_url":"https://clinicaltrials.gov/study/NCT04850599","title":"A Single-Arm Phase II Study of Isatuximab With Carfilzomib and Pomalidomide in Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-06-14","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05605535","publication_url":"https://clinicaltrials.gov/study/NCT05605535","title":"A Phase 2, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial Comparing Chemoimmunotherapy (Paclitaxel-Carboplatin-Oregovomab) Versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) as Neoadjuvant Therapy in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma","has_exemption":false,"start_date":"2023-02-07","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"CanariaBio Inc.","sponsor_slug":"canariabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06720350","publication_url":"https://clinicaltrials.gov/study/NCT06720350","title":"Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures","has_exemption":false,"start_date":"2025-01-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Marmara University","sponsor_slug":"marmara-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06795048","publication_url":"https://clinicaltrials.gov/study/NCT06795048","title":"A Phase IIIb/IV, Multicenter, Randomized, Open-Label, Two-Arm Study to Investigate the Efficacy, Safety, and Durability of Faricimab Administered up to Every 24 Weeks in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-03-14","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06894511","publication_url":"https://clinicaltrials.gov/study/NCT06894511","title":"A Phase II, Open-label, Multi-Center, Randomized Study of Combination of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) and Androgen Receptor Pathway Inhibitor (ARPI) vs. Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in First-line Treatment of Patients With Prostate-Specific Membrane Antigen (PSMA)-Positive Progressive Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-09-11","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111494","publication_url":"https://clinicaltrials.gov/study/NCT07111494","title":"Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497672","publication_url":"https://clinicaltrials.gov/study/NCT07497672","title":"Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study","has_exemption":false,"start_date":"2026-04-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Myoptechs, Inc","sponsor_slug":"myoptechs-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07545980","publication_url":"https://clinicaltrials.gov/study/NCT07545980","title":"Open-Label Proof-of-Concept Study of CelluJuve® for the Treatment of Moderate to Severe Nasolabial Folds","has_exemption":false,"start_date":"2026-04-29","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Spiderwort Biotechnologies Inc.","sponsor_slug":"spiderwort-biotechnologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03533283","publication_url":"https://clinicaltrials.gov/study/NCT03533283","title":"An Open-Label, Multi-Center, Phase IB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin (Plus a Single Pre-Treatment Dose of Obinutuzumab) in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2018-05-08","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06028022","publication_url":"https://clinicaltrials.gov/study/NCT06028022","title":"Reishi Mushroom Extract for Fatigue and/or Arthralgias in Patients With Breast Cancer on Aromatase Inhibitors: A Randomized Phase II MNCCTN Trial","has_exemption":false,"start_date":"2023-10-18","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05977907","publication_url":"https://clinicaltrials.gov/study/NCT05977907","title":"Neoadjuvant Pembrolizumab and IO102-103 Prior to Curative-intent Surgical Care for Squamous Cell Carcinoma of the Head and Neck (SCCHN)","has_exemption":false,"start_date":"2023-12-14","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054776","publication_url":"https://clinicaltrials.gov/study/NCT06054776","title":"A Phase 2 Study of Glofitamab With Acalabrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06722157","publication_url":"https://clinicaltrials.gov/study/NCT06722157","title":"Randomized, Double-masked, Active-controlled, Multicenter Study to Evaluate Efficacy and Safety of Two Regimens of Intravitreal BI 771716 Against Pegcetacoplan in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration VERDANT Trial","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671002","publication_url":"https://clinicaltrials.gov/study/NCT06671002","title":"Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids (CARES for Kids) Trial","has_exemption":false,"start_date":"2025-01-10","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07033585","publication_url":"https://clinicaltrials.gov/study/NCT07033585","title":"Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-10-18","has_results":false,"results_due":false,"sponsor_name":"Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair","sponsor_slug":"han-xu-md-phd-fapcr-sponsor-investigator-irb-chair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03953300","publication_url":"https://clinicaltrials.gov/study/NCT03953300","title":"A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics","has_exemption":false,"start_date":"2019-10-08","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05100472","publication_url":"https://clinicaltrials.gov/study/NCT05100472","title":"Phase II Trial of Short Course Androgen Deprivation, Hypofractionated Pelvic Radiation and a Brachytherapy Boost for NCCN High-Risk Prostate Cancer With Low-Intermediate Risk Decipher Genomic Score","has_exemption":false,"start_date":"2021-10-19","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05617677","publication_url":"https://clinicaltrials.gov/study/NCT05617677","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05620407","publication_url":"https://clinicaltrials.gov/study/NCT05620407","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05995964","publication_url":"https://clinicaltrials.gov/study/NCT05995964","title":"A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-07275315 AND PF-07264660 IN ADULT PARTICIPANTS WITH MODERATE-SEVERE ATOPIC DERMATITIS","has_exemption":false,"start_date":"2023-08-22","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06376045","publication_url":"https://clinicaltrials.gov/study/NCT06376045","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma","has_exemption":false,"start_date":"2024-05-24","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516952","publication_url":"https://clinicaltrials.gov/study/NCT06516952","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis","has_exemption":false,"start_date":"2024-10-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516965","publication_url":"https://clinicaltrials.gov/study/NCT06516965","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis","has_exemption":false,"start_date":"2024-10-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698822","publication_url":"https://clinicaltrials.gov/study/NCT06698822","title":"A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531565","publication_url":"https://clinicaltrials.gov/study/NCT05531565","title":"A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05875168","publication_url":"https://clinicaltrials.gov/study/NCT05875168","title":"Phase 1/2, Open-label, Multicenter, First-in-Human Study of DS-3939a in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-08-18","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311682","publication_url":"https://clinicaltrials.gov/study/NCT06311682","title":"A Phase 3 Multi-center Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children (Age 2 to <12 Years) and Infants (Age 6 Months to <2 Years) With Moderate-to-severe Atopic Dermatitis. The Trial is Randomized, Double-blind, Placebo-controlled, and Parallel-group for Children (Age 2 to <12 Years) and Open-label and Single-group for Infants (Age 6 Months to <2 Years)","has_exemption":false,"start_date":"2024-06-10","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"LEO Pharma","sponsor_slug":"leo-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06894212","publication_url":"https://clinicaltrials.gov/study/NCT06894212","title":"A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07122843","publication_url":"https://clinicaltrials.gov/study/NCT07122843","title":"Real Time Guided Meditations for Pain in Virtual Reality Study","has_exemption":false,"start_date":"2025-11-06","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Christopher Almario","sponsor_slug":"christopher-almario","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477704","publication_url":"https://clinicaltrials.gov/study/NCT07477704","title":"A Randomized, Open-Label, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Weekly Alirocumab in Adults With Hypercholesterolemia","has_exemption":false,"start_date":"2026-04-14","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587311","publication_url":"https://clinicaltrials.gov/study/NCT03587311","title":"A Randomized Phase 2 Study of Bevacizumab and Either Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant or Platinum Refractory Ovarian Cancer","has_exemption":false,"start_date":"2018-10-12","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05208307","publication_url":"https://clinicaltrials.gov/study/NCT05208307","title":"Maintenance Therapy With Belantamab, Pomalidomide and Dexamethasone (BPd) in High-Risk Myeloma Patients: A Phase 2 Study With a Safety Run-In","has_exemption":false,"start_date":"2022-07-21","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668766","publication_url":"https://clinicaltrials.gov/study/NCT06668766","title":"Superior Ultrasound-Guided Venous Access: Single-Lumen Midline Catheters vs Long Peripheral IVs for Difficult IV Access in the Emergency Department, A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282275","publication_url":"https://clinicaltrials.gov/study/NCT07282275","title":"How Does Continued Use of Green Light Therapy Impact Outcomes?","has_exemption":false,"start_date":"2025-10-21","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03523858","publication_url":"https://clinicaltrials.gov/study/NCT03523858","title":"An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients With Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2018-05-28","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04992624","publication_url":"https://clinicaltrials.gov/study/NCT04992624","title":"Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee","has_exemption":false,"start_date":"2022-02-22","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Steven E Harte, PhD","sponsor_slug":"steven-e-harte-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06245408","publication_url":"https://clinicaltrials.gov/study/NCT06245408","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-Severe Symptom State (HZNP-DAZ-303)","has_exemption":false,"start_date":"2024-04-08","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07403669","publication_url":"https://clinicaltrials.gov/study/NCT07403669","title":"Cardiovascular Kidney and Metaboolic (CKM) Health Assessment and Patient Empowerment in chROnic Disease Using a Health Coach INtervention ModEl: A Randomized Clinical Trial","has_exemption":false,"start_date":"2025-10-22","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Aventyn, Inc.","sponsor_slug":"aventyn-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05859334","publication_url":"https://clinicaltrials.gov/study/NCT05859334","title":"A Phase 2 Study of Erdafitinib in Patients With Recurrent or Progressive IDH-Wild Type Glioma With an FGFR-TACC Gene Fusion","has_exemption":false,"start_date":"2024-01-04","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07476339","publication_url":"https://clinicaltrials.gov/study/NCT07476339","title":"A Multi-Center, Single-Arm, Open-Label, Prospective, Phase 4 Study to Investigate the Safety and Efficacy of Rapidly Restarting Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Viremic and Virologically-Suppressed Male and Female HIV-Positive Patients Aged ≥18 Years Who Are Treatment-Experienced and Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks","has_exemption":false,"start_date":"2026-03-23","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"CAN Community Health","sponsor_slug":"can-community-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07230964","publication_url":"https://clinicaltrials.gov/study/NCT07230964","title":"Early Feasibility Study of the Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"Dermed Diagnostics, Inc.","sponsor_slug":"dermed-diagnostics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221682","publication_url":"https://clinicaltrials.gov/study/NCT07221682","title":"Comparison For Ease Of Spinal Positioning & Duration Of Post-Op Analgesia Between Ultrasound Guided Supra-Inguinal Fascia Iliaca Block Vs Ultrasound Guided Infra-Inguinal Fascia Iliaca Block In Patients Undergoing Thigh & Knee Surgeries","has_exemption":false,"start_date":"2024-05-06","completion_date":"2026-10-25","has_results":false,"results_due":false,"sponsor_name":"Sahiwal medical college sahiwal","sponsor_slug":"sahiwal-medical-college-sahiwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04204616","publication_url":"https://clinicaltrials.gov/study/NCT04204616","title":"A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis","has_exemption":false,"start_date":"2021-01-11","completion_date":"2026-10-26","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05360446","publication_url":"https://clinicaltrials.gov/study/NCT05360446","title":"A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events (VICTORION-PLAQUE)","has_exemption":false,"start_date":"2022-07-08","completion_date":"2026-10-26","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05775159","publication_url":"https://clinicaltrials.gov/study/NCT05775159","title":"A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)","has_exemption":false,"start_date":"2023-04-24","completion_date":"2026-10-27","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789757","publication_url":"https://clinicaltrials.gov/study/NCT06789757","title":"An Open Label Phase II Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-10-27","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05168930","publication_url":"https://clinicaltrials.gov/study/NCT05168930","title":"A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05239728","publication_url":"https://clinicaltrials.gov/study/NCT05239728","title":"A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy (MK-6482-022)","has_exemption":false,"start_date":"2022-03-15","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04736706","publication_url":"https://clinicaltrials.gov/study/NCT04736706","title":"An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, as First-Line Treatment in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)","has_exemption":false,"start_date":"2021-04-14","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05653349","publication_url":"https://clinicaltrials.gov/study/NCT05653349","title":"A Phase III, Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (VAYHIT1)","has_exemption":false,"start_date":"2023-02-03","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05973773","publication_url":"https://clinicaltrials.gov/study/NCT05973773","title":"Randomized, Controlled, Open-label, Phase 3, Global Multi - Center Trial to Assess the Efficacy and Safety of Zipalertinib Plus Chemotherapy Versus Chemotherapy Alone, in Patients With Previously Untreated, Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations","has_exemption":false,"start_date":"2023-12-18","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06260033","publication_url":"https://clinicaltrials.gov/study/NCT06260033","title":"A Phase II Trial of Stereotactic Body Radiation Therapy and Fluoroestradiol Positron Emission Tomography in Patients With Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-07-23","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668376","publication_url":"https://clinicaltrials.gov/study/NCT06668376","title":"A Study to Evaluate the Incrediwear Products Immediately After ACL or ACL+MCL Arthroscopic Surgery","has_exemption":false,"start_date":"2024-10-29","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Texas Bone and Joint","sponsor_slug":"texas-bone-and-joint","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02843035","publication_url":"https://clinicaltrials.gov/study/NCT02843035","title":"A 4-part, Open-label, Multicenter, Multinational Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic, and Exploratory Efficacy of Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension","has_exemption":false,"start_date":"2017-01-04","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Genzyme, a Sanofi Company","sponsor_slug":"genzyme-a-sanofi-company","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03452202","publication_url":"https://clinicaltrials.gov/study/NCT03452202","title":"Using tDCS in Speech-based Stroke Rehabilitation","has_exemption":false,"start_date":"2019-01-11","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04041310","publication_url":"https://clinicaltrials.gov/study/NCT04041310","title":"A Phase I/II, Multicenter, Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors","has_exemption":false,"start_date":"2019-10-21","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Nouscom SRL","sponsor_slug":"nouscom-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04198766","publication_url":"https://clinicaltrials.gov/study/NCT04198766","title":"An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Multicohort, Phase 1/2 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2019-12-10","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Inhibrx Biosciences, Inc","sponsor_slug":"inhibrx-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565665","publication_url":"https://clinicaltrials.gov/study/NCT04565665","title":"Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia","has_exemption":false,"start_date":"2020-07-29","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04582279","publication_url":"https://clinicaltrials.gov/study/NCT04582279","title":"Application of Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Asymptomatic Lung Transplant Recipients","has_exemption":false,"start_date":"2020-10-28","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04675710","publication_url":"https://clinicaltrials.gov/study/NCT04675710","title":"Pembrolizumab in Combination With Dabrafenib and Trametinib as a Neoadjuvant Strategy Prior to Surgery in BRAF-Mutated Anaplastic Thyroid Cancer","has_exemption":false,"start_date":"2021-06-24","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04793412","publication_url":"https://clinicaltrials.gov/study/NCT04793412","title":"Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05007873","publication_url":"https://clinicaltrials.gov/study/NCT05007873","title":"Phase II Study Assessing Safety and Clinical Activity of the Combination of ASTX727 With Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)","has_exemption":false,"start_date":"2021-10-21","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851613","publication_url":"https://clinicaltrials.gov/study/NCT04851613","title":"A Phase Ib/III Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Laekna Limited","sponsor_slug":"laekna-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444257","publication_url":"https://clinicaltrials.gov/study/NCT05444257","title":"A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121/TEZ/D-IVA Combination Therapy in Subjects With Cystic Fibrosis","has_exemption":false,"start_date":"2022-11-08","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05340465","publication_url":"https://clinicaltrials.gov/study/NCT05340465","title":"Trial of Darbepoetin Plus Slow-release Intravenous Iron to Decrease Transfusions and Improve Iron Status and Neurodevelopment in Preterm Infants","has_exemption":false,"start_date":"2022-11-27","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05293600","publication_url":"https://clinicaltrials.gov/study/NCT05293600","title":"Treating Residual OSA With Endotype-directed Pharmacotherapy (Aim 3)","has_exemption":false,"start_date":"2023-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972018","publication_url":"https://clinicaltrials.gov/study/NCT05972018","title":"Liposomal Bupivacaine/Bupivacaine A Single-Dose Bilateral Rectus Sheath Blocks Versus Ropivacaine in Bilateral Rectus Sheath Blocks And Catheters With Intermittent Hourly Boluses.","has_exemption":false,"start_date":"2023-10-18","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Hartford Hospital","sponsor_slug":"hartford-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06385925","publication_url":"https://clinicaltrials.gov/study/NCT06385925","title":"Phase 1/2 Study of TSN1611 in Subjects With Advanced Solid Tumors Harboring KRAS G12D Mutation","has_exemption":false,"start_date":"2024-04-29","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Tyligand Pharmaceuticals (Suzhou) Limited","sponsor_slug":"tyligand-pharmaceuticals-suzhou-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06218706","publication_url":"https://clinicaltrials.gov/study/NCT06218706","title":"A Randomized, Sham-Controlled Trial Investigating Low Intensity Focused Ultrasound as a Novel Treatment for Refractory Opioid Use Disorder","has_exemption":false,"start_date":"2024-05-09","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Ali Rezai","sponsor_slug":"ali-rezai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233799","publication_url":"https://clinicaltrials.gov/study/NCT06233799","title":"Randomized, Placebo-Controlled, Multi-Site Trial of Extended-Release Naltrexone Injection/Bupropion XL Tablets in the Treatment of Methamphetamine Use Disorder","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"National Institute on Drug Abuse (NIDA)","sponsor_slug":"national-institute-on-drug-abuse-nida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06143306","publication_url":"https://clinicaltrials.gov/study/NCT06143306","title":"Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement","has_exemption":false,"start_date":"2024-08-14","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06641765","publication_url":"https://clinicaltrials.gov/study/NCT06641765","title":"Continuous Glucose Monitoring in Haemodialysis and Peritoneal Dialysis Patients With Type 1 and Type 2 Diabetes","has_exemption":false,"start_date":"2024-11-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Bo Feldt-Rasmussen","sponsor_slug":"bo-feldt-rasmussen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06923891","publication_url":"https://clinicaltrials.gov/study/NCT06923891","title":"An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients","has_exemption":false,"start_date":"2025-04-16","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Vanguard Research Group","sponsor_slug":"vanguard-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07240831","publication_url":"https://clinicaltrials.gov/study/NCT07240831","title":"Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Biobeat Technologies Ltd.","sponsor_slug":"biobeat-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07005050","publication_url":"https://clinicaltrials.gov/study/NCT07005050","title":"Renal Pelvic Denervation Pilot Trial","has_exemption":false,"start_date":"2025-12-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Verve Medical, Inc","sponsor_slug":"verve-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07312006","publication_url":"https://clinicaltrials.gov/study/NCT07312006","title":"Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The \"CAT5-GS\" Study","has_exemption":false,"start_date":"2026-01-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"SurgiQuest, Inc.","sponsor_slug":"surgiquest-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06965621","publication_url":"https://clinicaltrials.gov/study/NCT06965621","title":"An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With Heart Failure and Implantable Cardioverter-Defibrillators","has_exemption":false,"start_date":"2026-04-28","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)","sponsor_slug":"innervate-radiopharmaceuticals-llc-formerly-illumina-radiopharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288047","publication_url":"https://clinicaltrials.gov/study/NCT07288047","title":"Virtual Reality as an Adjunctive Agent for the Management of Pain and Anxiety During First Trimester Procedural Abortion: a Randomized Controlled Trial","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Study Investigator","sponsor_slug":"study-investigator","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400666","publication_url":"https://clinicaltrials.gov/study/NCT07400666","title":"Intra-gastrointestinal Monitoring Device (PressureDOT®) and Centurion Intra-abdominal Pressure Monitoring Device Comparison Study: Pivotal Study of Safety and Performance.","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Dotspace Inc.","sponsor_slug":"dotspace-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07490496","publication_url":"https://clinicaltrials.gov/study/NCT07490496","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Cali Pharmaceuticals LLC","sponsor_slug":"cali-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00508443","publication_url":"https://clinicaltrials.gov/study/NCT00508443","title":"Phase I/II Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) for the Treatment of Metastatic Spine Disease","has_exemption":false,"start_date":"2002-10-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00077285","publication_url":"https://clinicaltrials.gov/study/NCT00077285","title":"A Pilot Phase II Trial Of Irinotecan Plus Carboplatin, And Irinotecan Maintenance Therapy (High-Risk Patients Only), Integrated Into The Upfront Therapy Of Newly Diagnosed Patients With Intermediate - And High-Risk Rhabdomyosarcoma","has_exemption":false,"start_date":"2003-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00501826","publication_url":"https://clinicaltrials.gov/study/NCT00501826","title":"Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated T-ALL and Lymphoblastic Lymphoma","has_exemption":false,"start_date":"2007-07-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00869232","publication_url":"https://clinicaltrials.gov/study/NCT00869232","title":"UARK 2008-02, A Phase II Trial for High-risk Myeloma Evaluation Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-host-exhausting and Timely Dose-reduced MEL-80-VRD-PACE Tandem Transplants","has_exemption":false,"start_date":"2008-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01189786","publication_url":"https://clinicaltrials.gov/study/NCT01189786","title":"Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection (EXCESS)","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01223248","publication_url":"https://clinicaltrials.gov/study/NCT01223248","title":"A Phase III Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients With Metastatic Cancer","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01269853","publication_url":"https://clinicaltrials.gov/study/NCT01269853","title":"Phase I/II Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab (Avastin) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma.","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01220583","publication_url":"https://clinicaltrials.gov/study/NCT01220583","title":"A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors","has_exemption":false,"start_date":"2011-01-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Radiation Therapy Oncology Group","sponsor_slug":"radiation-therapy-oncology-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02178410","publication_url":"https://clinicaltrials.gov/study/NCT02178410","title":"Vitamin D and Omega-3 Trial (VITAL Rhythm Study)","has_exemption":false,"start_date":"2012-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01881503","publication_url":"https://clinicaltrials.gov/study/NCT01881503","title":"Expanded Access Protocol for the Treatment Use of HBOC-201","has_exemption":false,"start_date":"2013-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Englewood Hospital and Medical Center","sponsor_slug":"englewood-hospital-and-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02015013","publication_url":"https://clinicaltrials.gov/study/NCT02015013","title":"Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models","has_exemption":false,"start_date":"2014-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02269150","publication_url":"https://clinicaltrials.gov/study/NCT02269150","title":"A Randomized Controlled Trial of Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02323867","publication_url":"https://clinicaltrials.gov/study/NCT02323867","title":"UNRELATED AND PARTIALLY MATCHED RELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH Alpha/Beta T CELL AND B CELL DEPLETION FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03119584","publication_url":"https://clinicaltrials.gov/study/NCT03119584","title":"Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial","has_exemption":false,"start_date":"2015-09-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Texas Tech University Health Sciences Center, El Paso","sponsor_slug":"texas-tech-university-health-sciences-center-el-paso","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02570542","publication_url":"https://clinicaltrials.gov/study/NCT02570542","title":"A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2015-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02725060","publication_url":"https://clinicaltrials.gov/study/NCT02725060","title":"Autoimmune Basis for Postural Tachycardia Syndrome","has_exemption":false,"start_date":"2016-02-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02716116","publication_url":"https://clinicaltrials.gov/study/NCT02716116","title":"A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 (AP32788) in Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2016-06-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02923570","publication_url":"https://clinicaltrials.gov/study/NCT02923570","title":"A Phase II Randomized Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Unilateral Head and Neck Cancer","has_exemption":false,"start_date":"2016-10-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02932280","publication_url":"https://clinicaltrials.gov/study/NCT02932280","title":"A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02921022","publication_url":"https://clinicaltrials.gov/study/NCT02921022","title":"Pilot Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03141684","publication_url":"https://clinicaltrials.gov/study/NCT03141684","title":"A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma","has_exemption":false,"start_date":"2017-04-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03122717","publication_url":"https://clinicaltrials.gov/study/NCT03122717","title":"A Phase 1/2 Study of Osimertinib in Combination With Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer","has_exemption":false,"start_date":"2017-05-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03168659","publication_url":"https://clinicaltrials.gov/study/NCT03168659","title":"Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation","has_exemption":false,"start_date":"2017-06-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03004287","publication_url":"https://clinicaltrials.gov/study/NCT03004287","title":"2015-12: A Phase II Study Exploring the Use of Early and Late Consolidation/Maintenance With Anti-CD38 (Protein) Monoclonal Antibody to Improve Progression Free Survival in Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2017-07-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03178552","publication_url":"https://clinicaltrials.gov/study/NCT03178552","title":"A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (B-FAST: Blood-First Assay Screening Trial)","has_exemption":false,"start_date":"2017-09-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03315910","publication_url":"https://clinicaltrials.gov/study/NCT03315910","title":"Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites","has_exemption":false,"start_date":"2017-10-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03323463","publication_url":"https://clinicaltrials.gov/study/NCT03323463","title":"A Prospective Single Arm Non-inferiority Trial of Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma (Major De-escalation to 30Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma)","has_exemption":false,"start_date":"2017-10-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03315026","publication_url":"https://clinicaltrials.gov/study/NCT03315026","title":"Phase II Study of Interleukin 6 Blockade With Siltuximab to Decrease Symptom Burden in Patients Age 60-75 Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma and AL Amyloidosis","has_exemption":false,"start_date":"2017-12-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03090165","publication_url":"https://clinicaltrials.gov/study/NCT03090165","title":"A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024","has_exemption":false,"start_date":"2018-05-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Kari Wisinski","sponsor_slug":"kari-wisinski","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03716167","publication_url":"https://clinicaltrials.gov/study/NCT03716167","title":"Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers","has_exemption":false,"start_date":"2018-07-27","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03693014","publication_url":"https://clinicaltrials.gov/study/NCT03693014","title":"A Phase II Trial of Hypofractionated Radiotherapy in Patients With Limited Progression on Immune Checkpoint Blockade","has_exemption":false,"start_date":"2018-10-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03705234","publication_url":"https://clinicaltrials.gov/study/NCT03705234","title":"HPS-4/TIMI 65/ORION-4: A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease","has_exemption":false,"start_date":"2018-10-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Oxford","sponsor_slug":"university-of-oxford","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03607890","publication_url":"https://clinicaltrials.gov/study/NCT03607890","title":"Phase 2 Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor","has_exemption":false,"start_date":"2018-11-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03183895","publication_url":"https://clinicaltrials.gov/study/NCT03183895","title":"Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Ancora Heart, Inc.","sponsor_slug":"ancora-heart-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04258462","publication_url":"https://clinicaltrials.gov/study/NCT04258462","title":"Hyperpolarized 13C Pyruvate Metabolic MRI to Predict Renal Tumor Aggressiveness","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Zhen Wang, MD","sponsor_slug":"zhen-wang-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03513939","publication_url":"https://clinicaltrials.gov/study/NCT03513939","title":"A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation","has_exemption":false,"start_date":"2019-02-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sernova Biotherapeutics Inc.","sponsor_slug":"sernova-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03184454","publication_url":"https://clinicaltrials.gov/study/NCT03184454","title":"Combined Cortical and Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder","has_exemption":false,"start_date":"2019-03-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null}]}